The cell cycle control pathway emerged as the major dysregulated pathway in HCC, including genetic variants of TP53 (70.7%), CDKN2A (13.5%), CTNNB1 (13.1%), RB1 (11.3%), and CDKN2B (8.1%). This evidence concerns the gene CDKN2B and hepatocellular carcinoma.